Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the bronchodilator efficacy and safety of tiotropium inhalation capsules (18 µg
once daily) and Atrovent® MDI (2 puffs of 20µg q.i.d.) among Filipino patients with COPD